Range International Valuation

Is RAN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of RAN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate RAN's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate RAN's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for RAN?

Key metric: As RAN is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for RAN. This is calculated by dividing RAN's market cap by their current revenue.
What is RAN's PS Ratio?
PS Ratio	1.9x
Sales	US$1.96m
Market Cap	US$3.72m

RAN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.8x
Enterprise Value/EBITDA	-1.6x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does RAN's PS Ratio compare to its peers?

The above table shows the PS ratio for RAN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	2.5x
CG1 Carbonxt Group	1.3x	n/a	AU$19.5m
MCO Myeco Group	1.4x	n/a	AU$20.9m
CXL Calix	6.5x	28.4%	AU$156.7m
SDV SciDev	0.9x	10.0%	AU$103.5m
RAN Range International	1.9x	n/a	AU$5.6m

Price-To-Sales vs Peers: RAN is expensive based on its Price-To-Sales Ratio (1.9x) compared to the peer average (0.9x).

Price to Sales Ratio vs Industry

How does RAN's PS Ratio compare vs other companies in the AU Chemicals Industry?

15 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	4.8x	9.9%
RAN Range International	1.9x	n/a	US$3.72m
ORI Orica	1.1x	4.0%	US$5.69b
IPL Incitec Pivot	1.1x	0.7%	US$3.90b

15 Companies		Estimated Growth	Market Cap
Industry Avg.	4.8x	34.5%
RAN Range International	1.9x	n/a	US$3.72m

No more companies

Price-To-Sales vs Industry: RAN is good value based on its Price-To-Sales Ratio (1.9x) compared to the Australian Chemicals industry average (3.7x).

Price to Sales Ratio vs Fair Ratio

What is RAN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

RAN PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	1.9x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate RAN's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Incitec Pivot

AU$6.0b

Manufactures and distributes industrial explosives, industrial chemicals, and fertilizers in Australia and the United State.

IPL

AU$3.19

1.3%

11.7%

Aurelia Metals

AU$304.5m

Engages in the exploration and production of mineral properties in Australia.

AMI

AU$0.17

66.7%

Nufarm

AU$1.5b

Develops, manufactures, and sells crop protection solutions and seed technologies in Europe, the Middle East, Africa, North America, and the Asia Pacific.

NUF

AU$3.95

-5.0%

-14.9%